---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-004249"
form_type: "8-K"
ticker: "XLO"
cik: "0001840233"
company_name: "Xilio Therapeutics, Inc."
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T06:32:38.035479+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Xilio Therapeutics issues 6.86M shares to Gilead at $1.97/share for $13.5M private placement

## Summary
- Closed private placement of 6,860,223 shares to Gilead Sciences at $1.97/share for ~$13.5M.
- Shares issued under an exclusive license agreement previously disclosed.
- Shares outstanding increased from 27,613,263 to 34,473,486.
- Placement closed on March 28, 2024, as part of strategic collaboration with Gilead.

## SEC filing metadata
- accession: 0001558370-24-004249
- form_type: 8-K
- ticker: XLO
- cik: 0001840233
- company_name: Xilio Therapeutics, Inc.
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840233/000155837024004249/0001558370-24-004249-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840233/000155837024004249/xlo-20240328x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-004249
- JSON: https://secwatch.observer/filing/0001558370-24-004249.json
- Plain text: https://secwatch.observer/filing/0001558370-24-004249.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.